Neudle.com: multiple sclerosis prophylaxsis

Differential
(Click to cross reference)

abortion, spontaneous

ACTH

acute disseminated encephalomyelitis

advances in neurology

adverse drug reaction

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, treatment of

anti JC virus antibodies

antihistamines

antineutrophil cytoplasmic autoantibodies

auditory and vestibular pathways

autoimmune disease

axonal degeneration

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

baclofen

bacterial infection

bacterial infection, CNS

Barkhof MR criteria for MS

bone marrow suppression

bone marrow transplantation

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

central nervous system, infection of

cerebral cortical atrophy

cerebral hypersensitivity, delayed

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrovascular accident, secondary prevention

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

clonus

cognition

coinfection

complementary medicine

congestive heart failure

contrast sensitivity

controversies in neurology

cranial neuropathy, multiple

cryptococcal meningitis

cyclophosphamide

cyclosporine

cytokines

cytomegalovirus infection

daclizumab

dantrolene sodium

degenerative diseases of CNS

delay in diagnosis

demyelinating disease

depression

dermatomyositis

dexamethasone suppression test

diagnostic criteria

diaminopyridine, 3, 4

diet

dietary supplement

differential diagnosis

digitalis

dilantin

disability rating scale, neurological

disability, neurological

disease modifying agents

dizziness

dorsal column stimulator

droperidol

drowsiness

drug holiday

drug induced neurologic disorders

ejection fraction, abnormal

electrocardiogram, abnormal

epidemiology of neurology

epidural steroid

Epstein-Barr virus

Epstein-Barr virus, negative

ethics in neurology

EVIDENCE trial

evidence-based research

evoked potentials

exercise

exercise-induced vascular symptoms

fingolimod, discontinuation

fundus, abnormality of

gadolinium

gag reflex, depressed

gait disorder

gamma amino butyric acid-mimetic drug

gammaglobulin therapy, intravenous

genetic neurologic disorders

granulomatosis with polyangiitis

grasp reflex

gray matter

guanidine

Guillain Barre syndrome

headache

hearing loss

hemophagocytic lymphohistiocytosis

hepatic failure

herniated disc, steroid treatment of

herpes simplex encephalitis

herpes simplex virus

herpes virus

herpes virus infection

herpes zoster

herpes zoster, disseminated

herpes zoster, ophthalmicus

hydrocephalus, exvacuo

hyperbaric oxygen

hyperbaric treatment

hyperhidrosis

hypersensitivity reaction

hypertension

hyperthermia

hypothermia

iatrogenic neurologic disorders

ibuprofen

idiopathic thrombocytopenic purpura

immune reconstitution inflammatory syndrome

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inclusion body myositis

infection

infliximab

infusion pump

infusion-associated reaction

interferon

interferon alpha

interferon antibodies

interferon beta 1-a

interferon beta 1-b

interferon gamma

interferon, intrathecal

interleukin 2

interleukin 6

internet

interobserver agreement

intrathecal antispasticity drugs

intrathecal steroid

intrauterine

intravenous

iron, serum, elevated

listeria monocytogenes

liver disease

liver function enzymes

lymphadenopathy

lymphoma

lymphoma, primary of CNS

McDonald criteria for MS

meclizine

medication withdrawal

melanoma, malignant

memory, impairment of

meningeal biopsy

meningeal enhancement

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, granulomatous

monoclonal antibodies

MRI, contrast enhanced

MRI, demyelinating disease

MRI, false negative

MRI, field strength, high

MRI, hypointense signal foci on

MRI, lesion burden

MRI, magnetization transfer sequence

multinucleated giant cell

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, aggressive

multiple sclerosis, asymptomatic

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, diet in

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, early onset

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, lesion location

multiple sclerosis, linoleic acid in

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, preclinical

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

multiple sclerosis, worsening

muscle atrophy, static

myasthenia gravis, drug induced

myasthenia gravis, treatment of

myasthenic syndrome

myasthenic syndrome, treatment of

N-acetyl-L-aspartic acid

natalizumab

natalizumab, discontinuation

nausea and vomiting

negative

neurofilament light chain protein

neurogenic bladder

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic examination

neuromyelitis optica (Devic's disease)

neuromyotonia

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuroprotective agents

neurosyphilis

neurotoxic

neurotoxin

neutralizing antibodies

nonsteroidal anti-inflammatory drug

ocrelizumab

ofatumumab

opportunistic infection

opportunistic infection, CNS

optic neuritis

optic neuritis, treatment of

optical coherence tomography

organ transplantation

outcome research

oxybutynin

pachymeningitis, cranial

Parkinson disease, L-dopa nonresponsive

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

paroxysmal neurologic deficits

patient information and support

pleocytosis of cerebrospinal fluid

pleurisy

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy, chronic inflammatory demyelinating

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primrose oil

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

psychological testing

quality of life

radiation therapy, CNS treatment and complications with

radiation therapy, total body

reversible neurologic disorder

review article

risk factors

risk stratification

risk-benefit assessment

rituximab

safety

sedimentation rate, elevated

seizure

serologic testing

seropositive

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

shared decision making

simvastatin

sinemet

skin, lesions in neurologic disorders

spasticity

spasticity, treatment of

spinal cord, injury of

spinal cord, injury, management of

statin therapy

stem cell transplantation

stereotaxic surgery

steroid

steroid therapy, CNS treatment and complications with

stiff man syndrome

stimulation, deep brain

subspecialist

sweating

sweating, abnormality of

syphilis, neurologic complications with

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

tuberculin skin test, positive

tumor necrosis factor

tumor necrosis factor inhibitor

urinary retention

urinary tract infection

urodynamics

vaccination, neurologic complications with

vaccine

valium

vasopressin

ventricular enlargement

vertigo

vertigo, cervical

vertigo, treatment of

viral infection

viral infection, CNS

viral infection, reactivation

visual acuity

visual acuity, decreased

visual evoked response

visual loss

vitamin D

vitamin supplementation

Showing articles 350 to 400 of 4024 << Previous Next >>

Systemic a-Interferon in Multiple Sclerosis, Long-Term Patient Follow-Up
Arch Neurol 44:61-63, Panitch,H.S., 1987

4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis
Ann Neurol 21:71-77, Stefoski,D.,et al, 1987

Intrathecally Administered Natural Human Fibroblast Interferon Reduces Exacerbations of Multiple Sclerosis
Arch Neurol 44:589-595, Jacobs,L.,et al, 1987

Total Lymphoid Irradiation in Multiple Sclerosis:Blood Lymphocytes & Clinical Course
Ann Neurol 22:634-638, Cook,S.D.,et al, 1987

Dexamethasone Suppression Test Abnormalities in Multiple Sclerosis:Relation to ACTH Therapy
Neurol 37:849-853, Reder,A.T.,et al, 1987

A Pilot Trial of Cop 1 in Exacerbating-Remitting Multiple Sclerosis
NEJM 317:408-414, 442-4441987., Bornstein,M.B.,et al, 1987

Multicentre Double-Blind Study of Intrathecally Admin Natural Human Fibroblast Interferon on Exacerb of MS
Lancet 2:1411-1413, Jacobs,L.,et al, 1986

Hyperbaric Oxygen in Multiple Sclerosis:A Double Blind Trial
BMJ 292:367-371, Wiles,C.M.,et al, 1986

Editorial on Multiple Sclerosis Treatments
Neurol 36:703-704, Scheinberg,L.C.&Van den Noort,S., 1986

Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986

Effect of Total Lymphoid Irradiation in Chronic Progressive Multiple Sclerosis
Lancet 1:1405-1409, Cook,S.D.,et al, 1986

Continuous Intrathecal Baclofen for Severe Spasticity
Lancet 2:125-127, Penn,R.D.&Kroin,J.S., 1985

Persistence of Antibrain Antibodies in Cerebrospinal Fluid During Plasmapheresis for Multiple Sclerosis
BMJ 291:850-851, Rybert,B.&Pirskanen,R., 1985

Intravenous Methylprednisolone for Multiple Sclerosis in Relapse
JNNP 48:157-159, Barnes,M.P.,et al, 1985

An Assessment of Plasma Exchange in Progressive Multiple Sclerosis
Neurol 35:320-322, Weiner,H.L., 1985

Use of Interferon in Multiple Sclerosis
Ann Neurol 18:432-433, McFarlin,D.E., 1985

Intrathecal Interferon in the Treatment of Multiple Sclerosis, Patient Follow-Up
Arch Neurol 42:841-847, Jacobs,L.,et al, 1985

Acute Improvement in Exacerbating Multiple Sclerosis Produced by Intravenous Administration of Mannitol
Ann Neurol 18:443-450, Stefoski,D.,et al, 1985

Anaphylactoid Reaction to Methylprednisolone Pulsed Therapy for Multiple Sclerosis
Neurol 34:1119-1121, Pryse-Phillips,W.E.,et al, 1984

Pain in Multiple Sclerosis
Arch Neurol 41:1270-1272, Clifford,D.B.,et al, 1984

Hyperbaric-Oxygen Treatment of Multiple Sclerosis
NEJM 308:181-186, Fischer,B.H.,et al, 1983

Intensive Immunosuppression in Progressive Multiple Sclerosis
NEJM 308:173-180, Hauser,S.L.,et al, 1983

Paroxysmal Limb Hemiataxia with Crossed Facial Paresthesias in Multiple Sclerosis
JAMA 250:2843-2844, Skillrud,D.M.,et al, 1983

Lympocytapheresis in Chronic Progressive Multiple Sclerosis:Results of a Preliminary Trial
Ann Neurol 14:593-594, Rose,J.,et al, 1983

Dorsal Column Stimulation in Multiple Sclerosis:Effects on Bladder & Long Term Findings
BMJ 287:793-795, Hawkes,C.H.,et al, 1983

Multiple Sclerosis, (Second of Two Parts)
NEJM 307:1246-1251, McFarlin,D.E.,et al, 1982

Intrathecal Interferon in Multiple Sclerosis
Arch Neurol 39:609-615, Jacobs,L.,et al, 1982

Treatment of Action Tremor in Multiple Sclerosis with Isoniazid
Neurol 32:912-913, Sabra,A.F.,et al, 1982

Treatment of Acute Exacerbations of Multiple Sclerosis with Intravenous Methylprednisone
JNNP 45:179-186, Buckley,C.,et al, 1982

Double-Blind Controlled Trial Of Immunosuppresion In The Treatment Of Multiple Sclerosis:Final Report
Lancet 2:351-354, Mertin,J.,et al, 1982

Intraspinal Steroid Therapy
Neurol 31:168-171, Bernat,J.L., 1981

Stimulation of Dorsal Column in Multiple Sclerosis
BMJ 280:889-891, Hawkes,C.H.,et al, 1980

Dorsal Column Stimulation in Multiple Sclerosis
Editorial, BMJ 280:1287-12881980., , 1980

Plasmapheresis in Multiple Sclerosis:Preliminary Findings
Neurol 30:1023-1028, Dau,P.C.,et al, 1980

Plasma Exchange:Aid to Therapy of Multiple Sclerosis
Neurol 30:1111, vandenNoort,S.,et al, 1980

Plasmapheresis in Multiple Sclerosis:Preliminary Study
Neurol 30:1029-1033, Weiner,H.L.,et al, 1980

Failure of Chronic Dorsal Column Stimulation in Multiple Sclerosis
Ann Neurol 6:66-67, Rosen,J.A.,et al, 1979

Baclofen for Spasticity in Multiple Sclerosis
Neurol 28:1094-1098, Feldman,R.G.,et al, 1978

Improvement in Multiple Sclerosis during Prolonged Induced Hypothermia
Neurol 27:302, Symington,G.R.,et al, 1977

Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975

Unsaturated Fatty Acids in M. S.
BMJ 2:777, , 1973

Recent Advances in MS
Med Clin North Am 56:1343, 1972, Nov., Poser,C., 1972

Complications from Intrathecal Steroid Therapy in Patients with MS
Neurol 22:454, Nelson,D.,et al, 1972

M. S. :Present Status of Therapy
The New Physician, March 1970 p. 224., Boshes,L., 1970

The Treatment of MS
Practitioner 192:62, Miller,H., 1964

Decompressive Carniectomy Plus Best Medical Treatment Versus Best Medical Treatment Alone for Spontaneous Severe Deep Supratentorial Intracerebral Haemorrhage:A Randomised Controlled Clinical Trial
Lancet 403:2395-2404, Beck,J.,et al, 2024

Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024

Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
Ann Neurol 96:846-854, Marrodan,M.,et al, 2024

Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024

Powassan Virus Encephalitis: A Tertiary Center Experience
Clin Inf Dis 78:80-89, Mendoza,M.A.,et al, 2024

Showing articles 350 to 400 of 4024 << Previous Next >>